Høydosebehandling med autolog stamcellestøtte ved lymfom - fra utprøvende til standard behandling

Tidsskrift for den Norske Laegeforening

Volumn 133, Issue 16, 2013, Pages 1735-1739

  Smeland, Knut Bjøro ^a   Kiserud, Cecilie E ^a   Lauritzsen, Grete F ^a   Fosså, Alexander ^a   Hammerstrøm, Jens ^b   Jetne, Vidar ^a   Kolstad, Arne ^a   Kvalheim, Gunnar ^a   Loge, Jon Håvard ^a,c   Løkeland, Turid ^d   Tangen, Jon Magnus ^a   Holte, Harald ^a   Kvaløy, Stein ^a,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; AUTOTRANSPLANTATION; CLINICAL PATHWAY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTORY; HUMAN; LYMPHOMA; MULTIMODALITY CANCER THERAPY; NORWAY; PRACTICE GUIDELINE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CRITICAL PATHWAYS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTORY, 20TH CENTURY; HUMANS; LYMPHOMA; NORWAY; PRACTICE GUIDELINES AS TOPIC; TRANSPLANTATION, AUTOLOGOUS;

EID: 84887356789     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: 10.4045/tidsskr.13.0319     Document Type: Article

References (35)

1. Schmitz N, Linch DC, Dreger P et al. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 1996; 347: 353 - 7.
2. Swerdlow SH, Campo E, Harris NL et al. WHO Classification of tumours of haematopoietic and lymphoid tissues. 4. utg. Lyon: IARC, 2008.
3. Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av maligne lymfomer nr. 987-82-8081-113-4/2012. Oslo: Norsk lymfomgruppe, 2012.
4. Cancer in Norway 2010 - cancer incidence, mortality, survival and prevalence in Norway 2012. Oslo: Kreftregisteret, 2012.
5. Freedman A. Follicular lymphoma: 2012 update on diagnosis and management. Am J Hematol 2012; 87: 988 - 95.
6. Bernstein SH, Burack WR. The incidence, natural history, biology, and treatment of transformed lymphomas. Hematology (Am Soc Hematol Educ Program) 2009; 2009: 532 - 41.
7. Osgood EE, Riddle MC, Matthews TJ. Aplastic anemia treated with daily transfusions and intravenous marrow. Case report. Ann Intern Med 1939; 13: 357 - 67.
8. Lorenz E, Uphoff D, Reid TR et al. Modification of irradiation injury in mice and guinea pigs by bone marrow injections. J Natl Cancer Inst 1951; 12: 197 - 201.
9. Pegg DE, Humble JG, Newton KA. The clinical application of bone marrow grafting. Br J Cancer 1962; 16: 417 - 35.
10. Appelbaum FR, Herzig GP, Ziegler JL et al. Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma. Blood 1978; 52: 85 - 95.
11. Bone-marrow autotransplantation in man. Report of an international cooperative study. Lancet 1986; 2: 960 - 2.
12. Schmitz N, Pfistner B, Sextro M et al. Aggressive conventional chemotherapy compared with highdose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial. Lancet 2002; 359: 2065 - 71.
13. Smeland S, Blystad AK, Kvaløy SO et al. Treatment of Burkitt's/Burkitt-like lymphoma in adolescents and adults: a 20-year experience from the Norwegian Radium Hospital with the use of three successive regimens. Ann Oncol 2004; 15: 1072 - 8.
14. Sweetenham JW, Santini G, Qian W et al. Highdose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/ maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma Group. J Clin Oncol 2001; 19: 2927 - 36.
15. Linch DC, Yung L, Smith P et al. Final analysis of the UKLG LY02 trial comparing 6 - 8 cycles of CHOP with 3 cycles of CHOP followed by a BEAM autograft in patients <65 years with poor prognosis histologically aggressive NHL. Br J Haematol 2010; 149: 237 - 43.
16. Blystad A, Kvalheim G, Torlakovic E et al. Highdose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non-Hodgkin's lymphoma. Bone Marrow Transplant 1999; 24: 865 - 72.
17. Eide MB, Lauritzsen GF, Kvalheim G et al. High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study. Br J Haematol 2011; 152: 600 - 10.
18. d'Amore F, Relander T, Lauritzsen GF et al. Upfront autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01. J Clin Oncol 2012; 30: 3093 - 9.
19. Blystad AK, Enblad G, Kvaløy SO et al. High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas. Bone Marrow Transplant 2001; 27: 711 - 6.
20. Schouten HC, Qian W, Kvaloy S et al. High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial. J Clin Oncol 2003; 21: 3918 - 27.
21. Andersen NS, Pedersen L, Elonen E et al. Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplant. Eur J Haematol 2003; 71: 73 - 80.
22. Geisler CH, Kolstad A, Laurell A et al. Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group. Blood 2008; 112: 2687 - 93.
23. Høydosebehandling med autolog stamcellestøtte ved maligne lidelser. Helsedirektoratets utredningsserie 1 - 951995. Oslo: Statens helsetilsyn, 1995.
24. Linch DC, Winfield D, Goldstone AH et al. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial. Lancet 1993; 341: 1051 - 4.
25. Ljungman P, Bregni M, Brune M et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplant 2010; 45: 219 - 34.
26. Hoppe RT, Advani RH, Ai WZ et al. Hodgkin lymphoma Version 2.2013. National Comprehensive Cancer Network Clinical Practice Guidelines. www.jnccn.org/content/10/5/589.short (25.4.2013).
27. Zelenetz AD, Abramson JS, Advani RH et al. Non-Hodgkin's lymphomas Version 1.2013. National Comprehensive Cancer Network Clinical Practice Guidelines. www.jnccn.org/content/11/3/ 257.abstract (25.4.2013).
28. Bosly A, Coiffier B, Gisselbrecht C et al. Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen. J Clin Oncol 1992; 10: 1615 - 23.
29. Philip T, Guglielmi C, Hagenbeek A et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 1995; 333: 1540 - 5.
30. Greb A, Bohlius J, Trelle S et al. High-dose chemotherapy with autologous stem cell support in firstline treatment of aggressive non-Hodgkin lymphoma - results of a comprehensive meta-analysis. Cancer Treat Rev 2007; 33: 338 - 46.
31. Schmitz N, Trümper L, Ziepert M et al. Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group. Blood 2010; 116: 3418 - 25.
32. Reimer P, Rüdiger T, Geissinger E et al. Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study. J Clin Oncol 2009; 27: 106 - 13.
33. Dreyling M, Lenz G, Hoster E et al. Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progressionfree survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network. Blood 2005; 105: 2677 - 84.
34. Schaaf M, Reiser M, Borchmann P et al. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults. Cochrane Database Syst Rev 2012; 1: CD007678.
35. Gisselbrecht C, Glass B, Mounier N et al. Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era. J Clin Oncol 2010; 28: 4184 - 90.